Edward Morrow Atkinson III, EVP, Chief Technical Operations Officer at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 4,228 shares at $420.79 ($1.8M) on 2024-02-20, disclosed to the SEC on 2024-02-21.
Scheduled sale ($1.8M) by EVP, Chief Technical Operations Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $424.01 | 1,501 | $636K | 35.7% |
| 2 | $420.58 | 1,125 | $473K | 26.5% |
| 3 | $420.79 | 801 | $337K | 18.9% |
| 4 | $420.79 | 801 | $337K | 18.9% |
| Total | $421.88 avg | 4,228 | $1.8M | 100% |
| Filing → |
| VRTX | SELL | 2026-02-12 | $806K | — | Filing → |
| VRTX | SELL | 2025-11-19 | $1.1M | — | Filing → |
| VRTX | SELL | 2025-02-28 | $1.3M | — | Filing → |